The influenza universe in an mRNA vaccine

doi:10.1126/science.adf0900

Comment

. 2022 Nov 25;378(6622):827-828.

doi: 10.1126/science.adf0900. Epub 2022 Nov 24.

The influenza universe in an mRNA vaccine

Alyson A Kelvin^{1

2}, Darryl Falzarano^{1

3}

Affiliations

¹ Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
² Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
³ Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

PMID: 36423290
DOI: 10.1126/science.adf0900

Comment

The influenza universe in an mRNA vaccine

Alyson A Kelvin et al. Science. 2022.

. 2022 Nov 25;378(6622):827-828.

doi: 10.1126/science.adf0900. Epub 2022 Nov 24.

Authors

Alyson A Kelvin^{1

2}, Darryl Falzarano^{1

3}

Affiliations

¹ Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
² Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
³ Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

PMID: 36423290
DOI: 10.1126/science.adf0900

Abstract

An mRNA-lipid nanoparticle vaccine protects animals from 20 influenza lineages.

PubMed Disclaimer

Comment on

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
Arevalo CP, Bolton MJ, Le Sage V, Ye N, Furey C, Muramatsu H, Alameh MG, Pardi N, Drapeau EM, Parkhouse K, Garretson T, Morris JS, Moncla LH, Tam YK, Fan SHY, Lakdawala SS, Weissman D, Hensley SE. Arevalo CP, et al. Science. 2022 Nov 25;378(6622):899-904. doi: 10.1126/science.abm0271. Epub 2022 Nov 24. Science. 2022. PMID: 36423275 Free PMC article.

Cited by

mRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNA.
Chaves LCS, Orr-Burks N, Vanover D, Mosur VV, Hosking SR, Kumar E K P, Jeong H, Jung Y, Assumpção JAF, Peck HE, Nelson SL, Burke KN, Garrison MA, Arthur RA, Claussen H, Heaton NS, Lafontaine ER, Hogan RJ, Zurla C, Santangelo PJ. Chaves LCS, et al. PLoS Pathog. 2024 Jul 5;20(7):e1012345. doi: 10.1371/journal.ppat.1012345. eCollection 2024 Jul. PLoS Pathog. 2024. PMID: 38968329 Free PMC article.
Cellular and Molecular Immunity to Influenza Viruses and Vaccines.
Kasten-Jolly J, Lawrence DA. Kasten-Jolly J, et al. Vaccines (Basel). 2024 Apr 7;12(4):389. doi: 10.3390/vaccines12040389. Vaccines (Basel). 2024. PMID: 38675771 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The influenza universe in an mRNA vaccine

Affiliations

The influenza universe in an mRNA vaccine

Authors

Affiliations

Abstract

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Abstract

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical